1. Home
  2. NAII vs CARA Comparison

NAII vs CARA Comparison

Compare NAII & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • CARA
  • Stock Information
  • Founded
  • NAII 1980
  • CARA 2004
  • Country
  • NAII United States
  • CARA United States
  • Employees
  • NAII N/A
  • CARA N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • CARA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAII Health Care
  • CARA Health Care
  • Exchange
  • NAII Nasdaq
  • CARA Nasdaq
  • Market Cap
  • NAII 23.7M
  • CARA 23.6M
  • IPO Year
  • NAII 1987
  • CARA 2014
  • Fundamental
  • Price
  • NAII $3.45
  • CARA $5.10
  • Analyst Decision
  • NAII
  • CARA Hold
  • Analyst Count
  • NAII 0
  • CARA 3
  • Target Price
  • NAII N/A
  • CARA $12.00
  • AVG Volume (30 Days)
  • NAII 10.2K
  • CARA 10.4K
  • Earning Date
  • NAII 05-13-2025
  • CARA 05-12-2025
  • Dividend Yield
  • NAII N/A
  • CARA N/A
  • EPS Growth
  • NAII N/A
  • CARA N/A
  • EPS
  • NAII N/A
  • CARA N/A
  • Revenue
  • NAII $121,853,000.00
  • CARA $7,137,000.00
  • Revenue This Year
  • NAII N/A
  • CARA N/A
  • Revenue Next Year
  • NAII N/A
  • CARA N/A
  • P/E Ratio
  • NAII N/A
  • CARA N/A
  • Revenue Growth
  • NAII N/A
  • CARA N/A
  • 52 Week Low
  • NAII $3.27
  • CARA $2.71
  • 52 Week High
  • NAII $7.26
  • CARA $11.39
  • Technical
  • Relative Strength Index (RSI)
  • NAII 41.39
  • CARA 49.07
  • Support Level
  • NAII $3.43
  • CARA $4.88
  • Resistance Level
  • NAII $3.62
  • CARA $5.15
  • Average True Range (ATR)
  • NAII 0.14
  • CARA 0.26
  • MACD
  • NAII 0.00
  • CARA -0.04
  • Stochastic Oscillator
  • NAII 4.08
  • CARA 25.89

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Share on Social Networks: